COMMUNIQUÉS West-GlobeNewswire

Repligen Corporation to Present at Upcoming September Conferences
22/08/2025
WALTHAM, Mass., Aug. 22, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be attending three upcoming [...]
Gyre Therapeutics Announces the Appointment of Dan Weng, M.D., to Board of Directors
22/08/2025
SAN DIEGO, Aug. 22, 2025 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), an innovative, commercial-stage biopharmaceutical company dedicated to advancing fibrosis-first therapies across organ systems [...]
Trading by management and close relations of management
22/08/2025
Please read the announcement in PDF Attachment 2025_39_Trading_By_Management
Flaggemelding
22/08/2025
Hawkeye Invest AS, et selskap som kontrolleres av Øystein Barmen, har i dag kjøpt 240 000 aksjer i PCI Biotech Holding ASA. Etter handelen eier Hawkeye Invest AS 2 000 000 aksjer, noe som utgjør 5,36% av aksjene i PCI [...]
CLINUVEL preparing upgrade of ADR program to Level II, Nasdaq uplist
22/08/2025
Executive summary plan to upgrade American Depository Receipt (ADR) program (CLVLY) to a Level II ADR listed on Nasdaq, expected before the end of 2025 CLINUVEL’s primary listing on the ASX will remain unchanged as a [...]
Financière de Tubize - Convening of the extraordinary general meeting of shareholders of Sep. 24, 2025
22/08/2025
Convening of the Extraordinary General Meeting of shareholders of 24 September 2025 The shareholders are invited to attend the extraordinary general meeting, which will take place on 24 September 2025 at 10:00AM, at [...]
Financière de Tubize - Convocation à l'assemblée générale extraordinaire du 24 septembre 2025
22/08/2025
Convocation des actionnaires à l’Assemblée Générale Extraordinaire du 24 septembre 2025 Les actionnaires sont invités à prendre part à l’assemblée générale extraordinaire qui se tiendra le 24 septembre 2025 à 10 heures [...]
Bavarian Nordic Announces First Half 2025 Results
22/08/2025
COPENHAGEN, Denmark, August 22, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today its interim financial results and business progress for the first half of 2025 and released its financial calendar for 2026. Revenue [...]
Calidi Biotherapeutics Announces Closing of $6.9 Million Underwritten Public Offering and Full Exercise of Underwriters’ Over-Allotment Option
22/08/2025
SAN DIEGO, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE AMERICAN: CLDI) (“Calidi” or the “Company”), a clinical-stage biotechnology company pioneering the development of targeted therapies with [...]

Pages